Stock MYLAN INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Mylan Inc Nasdaq

Equities

US6285301072

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Mylan Inc
18/04 Viatris' Proposed Femoston, Duphaston UK Rights Divestment Being Considered, CMA Says MT
18/04 UK Regulator to Consider Undertakings for Theramex-Viatris Deal MT

Chart calendar Mylan Inc

7927050363c2a61.Tt3LhAIGF3_MrbkgmYZMUzhq00iIb5h6oTKj_NfFaLw.D4mZsWlDQyeJ6sNkxvYIDBVa43DGWdEflWvOxJv8KoQjrP_rdTElB6Oczg~f485876709776b68640e2d8b9316aa39

Upcoming events on Mylan Inc

09/05/2024 Q1 2024 Earnings Release Pre-market
09/05/2024 06:00 pm Q1 2024 Earnings Call
14/05/2024 10:30 pm BofA Securities Health Care Conference
05/08/2024 Q2 2024 Earnings Release (Projected)
04/11/2024 Q3 2024 Earnings Release (Projected)
03/03/2025 Q4 2024 Earnings Release (Projected)
12/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Mylan Inc

27/03/2024 07:30 pm R&D Day
08/03/2024 Ex-dividend day
28/02/2024 07:00 pm Q4 2023 Earnings Call
28/02/2024 05:00 pm Q4 2023 Earnings Release
11/01/2024 12:00 am JPMorgan Healthcare Conference
15/12/2023 09:30 pm Annual General Meeting
22/11/2023 Ex-dividend day
15/11/2023 03:00 pm Jefferies London Healthcare Conference
08/11/2023 03:30 am Q3 2023 Earnings Call
08/11/2023 02:32 am Q3 2023 Earnings Release
23/08/2023 Ex-dividend day
07/08/2023 06:00 pm Q2 2023 Earnings Call
07/08/2023 04:29 pm Q2 2023 Earnings Release
14/06/2023 01:50 am Goldman Sachs Global Healthcare Conference
23/05/2023 Ex-dividend day
08/05/2023 06:00 pm Q1 2023 Earnings Call
08/05/2023 04:29 pm Q1 2023 Earnings Release
25/04/2023 03:00 am American Academy of Neurology Meeting - Poster #014
08/03/2023 Ex-dividend day
27/02/2023 07:00 pm Q4 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		11 501
11 537
-0.32%		11 946
12 273
-2.66%		17 886
17 881
0.03%		16 263
16 372
-0.67%		15 427
15 465
-0.25%
15 190

EBITDA
Million USD		Released
Forecast
Spread 		3 540
3 500
1.12%		3 654
4 483
-18.49%		6 426
6 464
-0.59%		5 777
5 852
-1.29%		5 124
5 197
-1.4%
4 865

EBIT
Million USD		Released
Forecast
Spread 		3 264
3 212
1.62%		3 376
3 864
-12.61%		6 046
6 111
-1.07%		5 475
5 566
-1.62%		4 725
4 851
-2.6%
4 543

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		154
807
-80.87%		-721
3 677
-119.61%		-664
-580
-14.55%		2 813
878
220.41%		203
1 198
-83.06%
4 099

Net income
Million USD		Released
Forecast
Spread 		16,8
427
-96.07%		-670
1 449
-146.24%		-1 269
-952
-33.29%		2 079
1 328
56.46%		54,7
812
-93.26%
1 858

EPS
USD		Released
Forecast
Spread 		0,03
0,81
-96.3%		-1,11
1,62
-168.59%		-1,05
-0,77
-36.36%		1,71
1,01
69.62%		0,05
0,84
-94.02%
1,39

Announcement Date27/02/2001/03/2128/02/2227/02/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		4 342
4 337
0.11%		4 192
4 258
-1.55%		4 117
4 185
-1.62%		4 078
4 136
-1.39%		3 876
3 988
-2.8%		3 729
3 812
-2.18%		3 919
3 862
1.45%		3 942
3 997
-1.37%		3 837
3 877
-1.03%
3 691


3 833


3 917


3 888


3 821

EBITDA
Million USD		Released
Forecast
Spread 		1 416
1 481
-4.39%		1 586
1 445
9.8%		1 482
1 443
2.73%		1 498
1 431
4.69%		1 211
1 288
-6%		1 341
1 222
9.69%		1 306
1 255
4.04%		1 360
1 293
5.2%		1 117
1 220
-8.44%
1 207


1 196


1 268


1 188




EBIT
Million USD		Released
Forecast
Spread 		1 314
1 383
-5.04%		1 551
1 375
12.82%		1 425
1 375
3.57%		1 415
1 368
3.4%		1 085
1 166
-6.96%		1 255
1 151
9.02%		1 226
1 178
4.12%		1 257
1 208
4.05%		987
1 100
-10.29%
1 104


1 133


1 191


1 114


1 131

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-204
-119
-71.34%		528
48,0
998.96%














402
260
54.69%		-855
140
-710.71%














Net income
Million USD		Released
Forecast
Spread 		-264
53,2
-595.86%		399
149
167.56%		314
234
34.21%		354
357
-0.78%		1 011
257
292.86%		225
154
46.31%		264
225
17.13%		332
246
35.03%		-766
114
-771.58%
123


144


188


188




EPS
USD		Released
Forecast
Spread 		-0,22
0,41
-154.32%		0,33
0,08
304.11%		0,26
0,19
36.43%		0,29
0,42
-31.07%		0,83
0,15
453%		0,19
0,23
-15.82%		0,22
0,20
8.2%		0,27
0,34
-20.08%		-0,64
0,26
-344.8%
0,12


0,14


0,23


0,30




Announcement Date28/02/2209/05/2208/08/2207/11/2227/02/2308/05/2307/08/2307/11/2328/02/24-----

Upcoming sector events for Mylan Inc

Today 10:30 am PHARMING GROUP N.V.: Q1 2024 Earnings Release
Today 04:30 pm TEVA PHARMACEUTICAL INDUSTRIES LIMITED: Q1 2024 Earnings Release
09/05/2024 SNDL INC.: Q1 2024 Earnings Release
09/05/2024 LIQUIDIA CORPORATION: Q1 2024 Earnings Release (Projected)
09/05/2024 ALEMBIC PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
09/05/2024 COLLEGIUM PHARMACEUTICAL, INC.: Q1 2024 Earnings Release
09/05/2024 ROYALTY PHARMA PLC: Q1 2024 Earnings Release
09/05/2024 VIATRIS INC.: Q1 2024 Earnings Release
09/05/2024 KAKEN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
09/05/2024 TSUMURA & CO.: Q4 2023 Earnings Release
More events

Past sector events for Mylan Inc

Today IMMUNOCORE HOLDINGS PLC: Q1 2024 Earnings Release (Projected)
Today AMPHASTAR PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
Today TARSUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
Today AVADEL PHARMACEUTICALS PLC: Q1 2024 Earnings Release
Today LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q1 2024 Earnings Release (Projected)
Today CAMURUS AB: Q1 2024 Earnings Release
Today BAVARIAN NORDIC A/S: Q1 2024 Earnings Release
08/05/2024 01:35 am SIGA TECHNOLOGIES, INC.: Q1 2024 Earnings Release
08/05/2024 01:31 am LIGAND PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release
08/05/2024 01:30 am OCULAR THERAPEUTIX, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. VTRS Stock
  4. Stock
  5. Calendar Mylan Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW